FDA Inspection 1134544 — ADC Therapeutics, SA
The FDA completed an inspection of ADC Therapeutics, SA on December 22, 2020 in New Providence, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 22, 2020
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- New Providence, NJ (United States)